XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.2
DISCONTINUED OPERATIONS (Tables)
9 Months Ended
Jun. 30, 2025
DISCONTINUED OPERATIONS  
Summary of discontinued operations presented in consolidated statements of operations and consolidated balance sheets

Three months Ended June 30,

Nine months Ended June 30,

    

2025

    

2024

    

2025

    

2024

Clinical laboratory service revenues

$

26,050

$

324,730

$

572,928

$

992,450

Cost of clinical laboratory service revenues

 

301,556

 

322,098

 

795,237

$

993,299

Gross profit

 

(275,506)

 

2,632

 

(222,309)

 

(849)

Selling, general and administrative

 

69,478

 

43,031

 

192,877

 

322,530

Interest (Income)

 

(25)

 

(6,608)

 

(3,302)

 

(50,982)

Other (income), net

 

(8,764)

 

 

(8,764)

 

Net loss from discontinued operations

 

(336,195)

 

(33,791)

 

(403,120)

 

(272,397)

Provision for income taxes

 

 

 

 

Net loss from discontinued operations, net of tax

$

(336,195)

$

(33,791)

$

(403,120)

$

(272,397)

    

June 30,

    

September 30,

2025

2024

ASSETS

Cash and cash equivalents

$

12,458

$

578,732

Accounts receivable, net

 

12,550

 

33,760

Inventories

 

 

5,867

Prepaid expenses and other current assets

 

 

59,787

Total current assets of discontinued operations

 

25,008

 

678,146

Property and equipment, net

 

11,264

 

94,337

Total assets of discontinued operations

 

36,272

 

772,483

LIABILITIES

 

  

 

  

Accounts payable and accrued liabilities

 

124,565

 

56,061

Total liabilities of discontinued operations

$

124,565

$

56,061